Publications

Gentry RP, Covington TR, Clewell HJ III. 2003. Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. Regul Toxicol Pharmacol 38(1):1–16; doi: 10.1016/S0273-2300(03)00047-3.

Proctor D, Panko J, Liebig E, Mundt K, Buczynski M, Barnhart R, Harris MA, Morgan R, Finley B, Paustenbach D. 2003. Workplace concentrations of airborne hexavalent chromium for the Painesville, Ohio chromate production plant. Appl Occup Environ Hyg 18(6):430-449; doi: 10.1080/10473220301421.

Luippold RS, Mundt KA, Austin RP, Liebig EW, Panko JM, Crump C, Crump K, Proctor DM. 2003. Lung cancer mortality among chromate production workers. J Occup Environ Med 60(6):451–457; doi: 10.1136/oem.60.6.451.

Crump C, Crump K, Hack E, Luippold R, Mundt K, Liebig EW, Panko JM, Paustenbach DJ, Proctor DM. 2003. Dose-response and risk assessment of airborne hexavalent chromium and lung cancer mortality. Risk Anal 23(6):1147–1163; doi: 10.1111/j.0272-4332.2003.00388.x.

Turesky RJ, Richoz J, Constable A, Curtis KD, Dingley KH, Turteltaub KW. 2003. The effects of coffee on enzymes involved in metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats. Chem-Biol Interact 145(3):251–265; doi: 10.1016/S0009-2797(03)00022-X. PMID: 12732453.

Dingley KH, Ubick EA, Chiarappa-Zucca ML, Nowell S, Abel S, Ebeler SE, et al. 2003. Effect of dietary constituents with chemopreventive potential on adduct formation of a low-dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes. Nutr Cancer 46(2):212–221; doi: 10.1207/S15327914NC4602_15. PMID: 14690798.

Martin EA, Gaskell M, Al-Azzawi F, Garner RC, Brown K, Boocock DJ, Mattock E, Pring DW, Dingley K, et al. 2003. Tamoxifen DNA damage detected in human endometrium using the ultra sensitive technique of accelerator mass spectrometry. Cancer Res 63(23):8461–8465. PMID: 14679010.

Peters JM, Aoyama T, Burns AM, Gonzalez FJ. 2003. Bezafibrate is a dual ligand for PPARalpha and PPARbeta: Studies using null mice. Biochim Biophys Acta 1632(1-3):80-89; doi: 10.1016/s1388-1981(03)00065-9. PMID: 12782154.

Hanna LA, Clegg MS, Momma T, Rogers JM, Daston GP, Keen CL. 2003. Zinc influences the in vitro development of peri-implantation mouse embryos. Birth Defects Res A 67(6):414–420; doi: 10.1002/bdra.10046.

Leazer TM, Daston GP, Keen CL, Rogers JM. 2003. The embryolethality of lipopolysaccharide in CD-1 and metallothionein I-II null mice: Lack of a role for induced zinc deficiency or metallothionein induction. Toxicol Sci 73(2):442–447; doi: 10.1093/toxsci/kfg088. PMID: 12700403.

Tarka-Leeds DK, Suarez JD, Roberts NL, Rogers JM, Hardy MP, Klinefelter GR. 2003. Gestational exposure to ethane dimethanesulfonate permanently alters reproductive competence in the CD-1 mouse. Biol Reprod 69(3):959–967; doi: 10.1095/biolreprod.103.017343. PMID: 12748126.

Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations. Toxicol Sci 74(2):369–381; doi: 10.1093/toxsci/kfg121.

Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol Sci 74(2):382–292; doi: 10.1093/toxsci/kfg122.

Rogers JM, Abbott BD. 2003. Screening for developmental toxicity of tobacco smoke constituents. Toxicol Sci 75(2):227–228; doi: 10.1093/toxsci/kfg215.

Tarka-Leeds DK, Herr DW, Klinefelter GR, Rogers JM. 2003. Effects of gestational exposure to ethane dimethanesulfonate in CD-1 mice: Microtia and preliminary hearing tests. Birth Defects Res B 68(4):383–390; doi: 10.1002/bdrb.10033.

Rogers JM, Setzer RW, Branch S, Chernoff N. 2003. Chemically-induced supernumerary ribs in CD-1 mice: Size distribution and dose-response. Birth Defects Res B 71(1):17–25; doi: 10.1002/bdrb.10055.

Sarangapani R, Gentry PR, Covington TR, Teeguarden JG, Clewell HJ. 2003. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal Toxicol 15(10):987–1016; doi: 10.1080/08958370390226350.

Gentry PR, Covington TR, Clewell HJ, Andersen ME. 2003. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone. J Toxicol Environ Health A 66(23):2209–2225; doi: 10.1080/713853996.

Tsuji JS, Williams PR, Edwards MR, Allamneni KP, Kelsh MA, Paustenbach DJ, et al. 2003. Evaluation of mercury in urine as an indicator of exposure to low levels of mercury vapor. EnvironHealth Perspect 111(4):623–630; doi:  10.1289/ehp.5717. PMID: 12676626.

Wheeler MW, Bailer AJ. 2003. A simulation study of methods for constructing confidence intervals for bioaccumulation factors. Environ Toxicol Chem 22(4):921-7; doi: 10.1002/etc.5620220433. PMID: 12685730.